Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Lin Liu

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Cancer Cell|April 11, 2025
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancerDing Ma, Lei-Jie Dai, Xiang-Rong Wu, et al.
Signal Transduction and Targeted Therapy|December 7, 2023
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicityYan Sun, Xiu-Na Yang, Shuang-Shuang Yang, et al.
Molecular Therapy Oncolytics|June 26, 2019
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLMYu-Shui Ma, Zhi-Jun Wu, Hong-Wei Zhang, et al.
Nature Genetics|September 28, 2023
Molecular classification of hormone receptor-positive HER2-negative breast cancerXi Jin, Yi-Fan Zhou, Ding Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2026
Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myelomaLu Jiang, Cheng-Lin Liu, Yu-Liang Zhang, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Cancer Cell|April 11, 2025
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancerDing Ma, Lei-Jie Dai, Xiang-Rong Wu, et al.
Signal Transduction and Targeted Therapy|December 7, 2023
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicityYan Sun, Xiu-Na Yang, Shuang-Shuang Yang, et al.
Molecular Therapy Oncolytics|June 26, 2019
Dual Regulatory Mechanisms of Expression and Mutation Involving Metabolism-Related Genes FDFT1 and UQCR5 during CLMYu-Shui Ma, Zhi-Jun Wu, Hong-Wei Zhang, et al.
Nature Genetics|September 28, 2023
Molecular classification of hormone receptor-positive HER2-negative breast cancerXi Jin, Yi-Fan Zhou, Ding Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2026
Molecular insight into the interplay among heterogeneous plasmacytes and microenvironment cells and their clinical relevance in myelomaLu Jiang, Cheng-Lin Liu, Yu-Liang Zhang, et al.
Nature Cancer|February 12, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilitiesYi-Zhou Jiang, Ding Ma, Xi Jin, et al.
Pageof 8